NCT03847220

Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 241 (actual)
• Sponsor: Spanish Breast Cancer Research Group · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: —

Summary

Epidemiological, prospective and multicenter study to evaluate the utility of the BOMET-QoL questionnaire in patients with breast cancer (BC) and bone metastases (BM).

Detailed description

Population: Patients over 18 with breast cancer and bone metastasis. Inclusion criteria: * Patient over 18 years of age. * Patient diagnosed with breast cancer (BC) and bone metastases (BM). * Patient who has granted informed consent in writing to participate in the study. * Patient capable of understanding and completing the questionnaires. Exclusion criteria: * Patient with another type of disease that, in the investigator's opinion, could mask the study results. * Patients with a life expectancy of less than 8 months. * Patient who is participating in a clinical trial with an unregistered drug at the start of the study.

Conditions

• Breast Carcinoma Metastatic to the Bone

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	BOMET-QoL questionnaire	study to evaluate the utility of the BOMET-QoL questionnaire in patients with BC and BM

Timeline

• Start date: 2007-10-23
• Primary completion: 2010-05-20
• Completion: 2012-07-07
• First posted: 2019-02-20
• Last updated: 2023-03-06

Locations

15 sites across 1 country: Spain